In August, the CTS Tampa lab transitioned to the same laboratory information systems (LIS) as the Dallas and Phoenix labs. The ability to test healthcare partner samples at any one of the three labs is a critical element in creating the reliability the CTS healthcare partners desire so they can provide the blood that saves patients’ lives.
By the end of 2017, CTS has secured three source plasma partners and continues to seek additional pa...
In January, CTS is incorporated as a non-profit organization owned by Vitalant and OneBlood (formerl...
CTS Tampa lab implements Dengue testing on behalf of a healthcare partner in an endemic area.
In August CTS begins source plasma testing as a new line of business to one of the largest plasma fr...
CTS Tampa lab implemented the Ortho Clinical Diagnostics VITROS® testing platform to perform COVID-1...
In July, the six viral marker assay conversion at CTS Dallas, Phoenix and Tampa laboratories was ach...